Enhanced expressions of arginine vasopressin (Avp) in the hypothalamic paraventricular and supraoptic nuclei of type 2 diabetic rats

Neurochemical Research

Volumn 33, Issue 5, 2008, Pages 833-841

  Yi, Sun Shin ^a   Hwang, In Koo ^a   Kim, Yo Na ^a   Kim, Il Yong ^a   Pak, Son Il ^b   Lee, In Se ^a   Seong, Je Kyung ^a   Yoon, Yeo Sung ^a  

^a Seoul National University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Arginine vasopressin; Paraventricular nucleus; Supraoptic nucleus; Type 2 diabetes; Zucker rat

Indexed keywords

ARGIPRESSIN; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR HYPOTHALAMUS; ARTICLE; CONTROLLED STUDY; FEMALE; FLUID INTAKE; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUPRAOPTIC NUCLEUS; WESTERN BLOTTING; ZUCKER DIABETIC FATTY RAT;

ANIMALS; ARGININE VASOPRESSIN; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, ZUCKER; SUPRAOPTIC NUCLEUS;

ANIMALIA; RATTUS;

EID: 41049095171     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9519-2     Document Type: Article

References (39)

1. Zelena D, Filaretova L, Mergl Z, Barna I, Toth ZE, Makara GB (2006) Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats. Am J Physiol Endocrinol Metab 290:243-250
2. Franco-Bourland RE (1998) Vasopressinergic, oxytocinergic, and somatostatinergic neuronal activity after adrenalectomy and immobilization stress. Neurochem Res 23:695-701
3. Medeiros Mdos S, Turner AJ (1996) Metabolism and function of neuropeptide Y. Neurochem Res 21:1125-1132
4. Antoni FA (1999) Vasopressinergic control pituitary adrenocorticotropin secretion comes of age. Clin Sci (Lond) 96:513-523
5. Scatt LV, Dinan TG (1998) Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci 62:1985-1998
6. Van Vugt DA, Lujan ME, Froats M, Krzemien A, Couceyro PR, Reid RL (2006) Effect of fasting on cocaine-amphetamine-regulated transcript, neuropeptide Y, and leptin receptor expression in the non-human primate hypothalamus. Neuroendocrinology 84:83-93
7. 1a receptor mRNA in diabetic (db/db) mice. Exp Clin Endocrinol Diabetes 109:261-266
8. Saravia FE, Gonzalez SL, Roig P, Alves V, Homo-Delarche F, De Nicola AF (2001) Diabetes increases the expression of hypothalamic neuropeptides in a spontaneous model of type I diabetes, the nonobese diabetic (NOD) mouse. Cell Mol Neurobiol 21:15-27
9. Hayashi M, Arima H, Goto M et al (2006) Vasopressin gene transcription increases in response to decrease in plasma volume, but not to increase in plasma osmolality, in chronically dehydrated rats. Am J Physiol Endocrinol Metab 290:E213-E217
10. Ludwig M, Callahan MF, Neumann I, Landgraf R, Morris M (1994) Systemic osmotic stimulation increases vasopressin and oxytocin release within the supraoptic nucleus. J Neuroendocrinol 6:369-373
11. Neumann I, Landgraf R, Bauce L, Pittman QJ (1995) Osmotic responsiveness and cross talk involving oxytocin, but not vasopressin or amino acids, between the supraoptic nuclei in virgin and lactating rats. J Neurosci 15:3408-3417
12. Bankir L, Bardoux P, Ahloulay M (2001) Vasopressin and diabetes mellitus. Nephron 87:8-18
13. Luo Y, Kaur C, Ling EA (2002) Neuronal and glial response in the rat hypothalamus-neurohypophysis complex with streptozotocin-induced diabetes. Brain Res 925:42-54
14. Yibchok-anun S, Abu-Basha EA, Yao CY, Panichkriangkrai W, Hsu WH (2004) The role of arginine vasopressin in diabetes-associated increase in glucagons secretion. Regul Pept 122:157-162
15. Kim MJ, Hong SJ, Yang J, Kim HK (2007) Silkworm (Bombyx mori L.) reduces vasopressin expression in the hypothalamus of streptozotocin-induced diabetic mice. Neurol Res 29:S72-S77
16. Chua SC Jr, Chung WK, Wu-Peng XS et al (1996) Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271:994-996
17. Lugarini F, Hrupka BJ, Schwartz GJ, Plata-Salaman CR, Langhans W (2005) Acute and chronic administration of immunomodulator induces anorexia in Zucker rats. Physiol Behav 84:165-173
18. Peterson RG (2001) The zucker diabetic fatty (ZDF) rat. In: Sima AAF, Shafrir E (eds) Animal models of diabetes a primer. Harwood academic publishers, Amsterdam, pp 109-128
19. Harmons JS, Gleason CE, Tanaka Y, Poitout V, Robertson RP (2001) Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats. Diabetes 50:2481-2486
20. Hwang IK, Yi SS, Kim YN et al (2007) Reduced hippocampal cell differentiation in the subgranular zone of the dentate gyrus in a rat model of type II diabetes. Neurochem Res doi. 10.1007/s11064-007-9940-8
21. Dheen ST, Tay SS, Wong WC (1994) Arginine vasopressin- and oxytocin-like immunoreactive neurons in the hypothalamic paraventricular and supraoptic nuclei of streptozotocin-induced diabetic rats. Arch Histol Cytol 57:461-472
22. Zelena D, Mergl Z, Makara GB (2006) The role of vasopressin in diabetes mellitus-induced hypothalamo-pituitary-adrenal axis activation: studies in Barttleboro rats. Brain Res Bull 69:48-56
23. Vokes TP, Aycinena PR, Rebertson GL (1987) Effect of insulin on osmoregulation of vasopressin. Am J Physiol 255:E538-E548
24. Chan O, Inouye K, Riddell MC, Vranic M, Matthews SG (2003) Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinol 28:87-102
25. Anai H, Ueta Y, Serino R et al (1997) Upregulation of the expression of vasopressin gene in the paraventricular and supraoptic nuclei of the lithium-induced diabetes insipidus rat. Brain Res 772:161-166
26. Gillard ER, Coburn CG, de Leon A et al (2007) Vasopressin autoreceptors and nitric oxide-dependent glutamate release are required for somatodendritic vasopressin release from rat magnocellular neuroendocrine cells responding to osmotic stimuli. Endocrinology 148:479-489
27. Fujiwara Y, Hiroyama M, Sanbe A et al (2007) Insulin hypersensitivity in mice lacking the V1b vasopressin receptor. J Physiol doi:10.1113/jphysiol.2007. 136481
28. Walsh CH, Baylis PH, Malins JM (1979) Plasma arginine vasopressin in diabetic ketoacidosis. Diabetologia 16:93-96
29. Zerbe RL, Vinicor F, Robertson GL (1979) Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 28:503-508
30. Hems DA, Ma GY (1976) Resistance to hepatic action of vasopressin in genetically obese (ob/ob) mice. Biochem J 160:23-28
31. McKenna K, Morris AD, Ryan M et al (2000) Renal resistance to vasopressin in poorly controlled type 1 diabetes mellitus. Am J Physiol Endocrinol Metab 279:E155-E160
32. Agha A, Smith D, Finucane F et al (2004) Attenuation of vasopressin-induced antidiuresis in poorly controlled type 2 diabetes. Am J Physiol Endocrinol Metab 287:E1100-E1106
33. Waldhausl W, Bratusch-Marrain P, Gasic S, Korn A, Nowotny P (1982) Insulin production rate, hepatic insulin retention, and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinemic type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 23:6-15
34. Aoyagi T, Birumachi J, Hiroyama M et al (2007) Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice. Endocrinology 148:2075-2084
35. Lee B, Yang C, Chen TH, al-Azawi N, Hsu WH (1995) Effect of AVP and oxytocin on insulin release: involvement of V1b receptor. Am J Physiol 269:E1095-E1100
36. 1b receptors. J Endocrinol 147:59-65
37. Yibchok-anun S, Cheng H, Heine PA, Hsu WH (1999) Characterization of receptors mediating AVP- and OT- induced glucagons release from the rat pancreas. Am J Physiol 277:E56-E62
38. Yibchok-anun S, Hsu WH (1998) Effects of arginine vasopressin and oxytocin on glucagons release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors. Life Sci 63:1871-1878
39. Folny V, Raufaste D, Likovic L et al (2003) Pancreatic vasopressin V1b receptors: characterization in In-R1-G9 cells and localization in human pancreas. Am J Physiol Endocrinol Metab 285:E566-E576